Morgan Stanley
AMED

Morgan Stanley’s Amedisys AMED Stock Holding History

Morgan Stanley’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-188,387
Closed -$18.5M – 8169
2025
Q2 		$18.5M Sell
188,387
-5,545
-3% -$525K ﹤0.01% 2892
2025
Q1 		$18M Sell
193,932
-49,112
-20% -$4.53M ﹤0.01% 2798
2024
Q4 		$22.1M Sell
243,044
-45,209
-16% -$4.15M ﹤0.01% 2653
2024
Q3 		$27.8M Buy
288,253
+117,440
+69% +$11.5M ﹤0.01% 2458
2024
Q2 		$15.7M Sell
170,813
-76,075
-31% -$7.06M ﹤0.01% 2927
2024
Q1 		$22.8M Sell
246,888
-264,474
-52% -$24.8M ﹤0.01% 2551
2023
Q4 		$48.6M Buy
511,362
+274,539
+116% +$25.6M ﹤0.01% 2492
2023
Q3 		$22.1M Buy
236,823
+35,782
+18% +$3.31M ﹤0.01% 2342
2023
Q2 		$18.4M Sell
201,041
-10,748
-5% -$882K ﹤0.01% 2560
2023
Q1 		$15.6M Buy
211,789
+51,554
+32% +$4.46M ﹤0.01% 2698
2022
Q4 		$13.4M Sell
160,235
-83,703
-34% -$7.55M ﹤0.01% 2766
2022
Q3 		$23.6M Sell
243,938
-14,442
-6% -$1.72M ﹤0.01% 2021
2022
Q2 		$27.2M Buy
258,380
+152,488
+144% +$19.5M ﹤0.01% 1951
2022
Q1 		$18.2M Sell
105,892
-50,463
-32% -$7.54M ﹤0.01% 2215
2021
Q4 		$25.3M Buy
156,355
+22,446
+17% +$3.61M ﹤0.01% 1914
2021
Q3 		$20M Buy
133,909
+1,726
+1% +$359K ﹤0.01% 2089
2021
Q2 		$32.4M Buy
132,183
+102,246
+342% +$26.8M ﹤0.01% 1675
2021
Q1 		$7.93M Sell
29,937
-11,421
-28% -$3.22M ﹤0.01% 2896
2020
Q4 		$12.1M Buy
41,358
+22,578
+120% +$5.79M ﹤0.01% 2305
2020
Q3 		$4.44M Buy
18,780
+6,325
+51% +$1.44M ﹤0.01% 2828
2020
Q2 		$2.47M Sell
12,455
-28,479
-70% -$5.31M ﹤0.01% 3388
2020
Q1 		$7.51M Sell
40,934
-32,743
-44% -$5.83M ﹤0.01% 2051
2019
Q4 		$12.3M Buy
73,677
+51,737
+236% +$7.69M ﹤0.01% 2177
2019
Q3 		$2.87M Buy
21,940
+10,479
+91% +$1.36M ﹤0.01% 3463
2019
Q2 		$1.39M Sell
11,461
-48,815
-81% -$5.79M ﹤0.01% 4033
2019
Q1 		$7.43M Sell
60,276
-230,035
-79% -$28.9M ﹤0.01% 2329
2018
Q4 		$34M Buy
290,311
+72,041
+33% +$8.49M 0.01% 1033
2018
Q3 		$27.3M Buy
218,270
+147,737
+209% +$16.3M 0.01% 1405
2018
Q2 		$6.03M Sell
70,533
-23,719
-25% -$1.74M ﹤0.01% 2935
2018
Q1 		$5.69M Buy
94,252
+6,312
+7% +$360K ﹤0.01% 2888
2017
Q4 		$4.63M Buy
87,940
+40,193
+84% +$2.12M ﹤0.01% 3188
2017
Q3 		$2.67M Sell
47,747
-36,204
-43% -$1.91M ﹤0.01% 3594
2017
Q2 		$5.27M Sell
83,951
-1,494
-2% -$87K ﹤0.01% 2778
2017
Q1 		$4.37M Sell
85,445
-82,508
-49% -$3.94M ﹤0.01% 2989
2016
Q4 		$7.16M Buy
167,953
+156,030
+1,309% +$6.63M ﹤0.01% 2616
2016
Q3 		$566K Sell
11,923
-92,653
-89% -$4.62M ﹤0.01% 4453
2016
Q2 		$5.28M Sell
104,576
-34,666
-25% -$1.75M ﹤0.01% 2566
2016
Q1 		$6.73M Sell
139,242
-190,968
-58% -$7.37M ﹤0.01% 2235
2015
Q4 		$13M Buy
330,210
+57,461
+21% +$2.3M ﹤0.01% 1761
2015
Q3 		$10.4M Buy
272,749
+32,052
+13% +$1.35M ﹤0.01% 1919
2015
Q2 		$9.56M Buy
240,697
+12,624
+6% +$393K ﹤0.01% 2162
2015
Q1 		$6.11M Buy
228,073
+89,139
+64% +$2.51M ﹤0.01% 2562
2014
Q4 		$4.08M Buy
138,934
+112,807
+432% +$2.79M ﹤0.01% 2919
2014
Q3 		$526K Sell
26,127
-3,123
-11% -$60.3K ﹤0.01% 4533
2014
Q2 		$490K Buy
29,250
+8,629
+42% +$122K ﹤0.01% 4584
2014
Q1 		$308K Sell
20,621
-10,084
-33% -$155K ﹤0.01% 4875
2013
Q4 		$449K Buy
30,705
+18,792
+158% +$303K ﹤0.01% 4527
2013
Q3 		$205K Sell
11,913
-17,751
-60% -$263K ﹤0.01% 4870
2013
Q2 		$343K Buy
+29,664
New +$340K ﹤0.01% 4518

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Morgan Stanley's AMED Position: Q3 2025 in Review

Morgan Stanley sold out of Amedisys (AMED) in Q3 2025, closing a stake of 188,387 shares — an estimated $18.5M sold.

Morgan Stanley first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $48.6M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Morgan Stanley reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Morgan Stanley sold 188,387 Amedisys shares in Q3 2025, an estimated $18.5M.
  • Morgan Stanley first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Morgan Stanley's Amedisys position peaked at $48.6M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.